Amlexanox, sold under the trade name Aphthasol, is an anti-inflammatory drug that is used to treat canker sores, asthma, and other conditions. It was first patented for use against canker sores in 1994.
Recently, A. R. Saltiel and co-workers at the University of Michigan (Ann Arbor) found that amlexanox is a promising treatment for type 2 diabetes and obesity. They showed that it inhibits two kinases in mice that are produced in the liver and fat in response to inflammation caused by a high-fat diet. Obese mice treated with amlexanox lost weight and became less insulin resistant.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.